"
Team:Waterloo/Checklist
From 2014.igem.org
m (Changed Virginia Tech to UoV) |
|||
| (One intermediate revision not shown) | |||
| Line 17: | Line 17: | ||
<p><b>Silver Achievements:</b></p> <p>Eight of the BioBricks have been characterized and we have documented the characterization of each part on its main registry page.</p><p> The characterized parts have been submitted to the parts registry, adhering to the registry guidelines.</p><p> We have considered the safety implications during the design of our project. </p> | <p><b>Silver Achievements:</b></p> <p>Eight of the BioBricks have been characterized and we have documented the characterization of each part on its main registry page.</p><p> The characterized parts have been submitted to the parts registry, adhering to the registry guidelines.</p><p> We have considered the safety implications during the design of our project. </p> | ||
| - | <p><b>Gold Achievements:</b></p> <p> We have improved an existing part in the registry by making it more versatile. | + | <p><b>Gold Achievements:</b></p> <p> We have improved an existing part in the registry by making it more versatile.</p><p> We have collaborated with UOttawa iGEM, University of Virginia, and other Ontario teams through OGEM.</p><p> Our project considers the ethics of synthetic biology treatments in medicine. </p> |
Latest revision as of 23:22, 21 November 2014
Checklist & Medal Criteria
CHECKLIST
Bronze Achievements:
Team registration.
We completed the Judging form.
We have created a wiki page to outline our project.
We submitted 19 new BioBricks.
Silver Achievements:
Eight of the BioBricks have been characterized and we have documented the characterization of each part on its main registry page.
The characterized parts have been submitted to the parts registry, adhering to the registry guidelines.
We have considered the safety implications during the design of our project.
Gold Achievements:
We have improved an existing part in the registry by making it more versatile.
We have collaborated with UOttawa iGEM, University of Virginia, and other Ontario teams through OGEM.
Our project considers the ethics of synthetic biology treatments in medicine.
